STAT

Teva reaches $85 million settlement on eve of opioid trial in Oklahoma

On the eve of a closely watched trial, Teva agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating…
A Teva Pharmaceutical facility building in Neot Hovav, Israel. Source: Tsafrir Abayov/AP

On the eve of a closely watched trial, Teva Pharmaceutical () agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating the benefits of its opioid painkillers and downplaying addictive risks that led doctors to

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
Solid Biosciences’ Duchenne Gene Therapy Trial Halted After Patient Suffers Serious Toxicity
The FDA has halted a clinical trial involving a Duchenne muscular dystrophy gene therapy from Solid Biosciences after a patient suffered serious kidney and blood-related injuries.
STAT10 min readTech
It’s Tiny Biotechs — Not Big Drug Makers — That Fear ‘Nuclear Winter’ From Pelosi’s Drug Pricing Bill
Washington hasn’t spent much time considering how small biotech companies will fare under Pelosi’s drug pricing bill — but CEOs said they predict a “devastating effect” on investment.
STAT4 min read
Opinion: Diabetic Foot Ulcers: A Silent Killer Of Veterans
The VA is a pioneer when it comes to detecting and treating diabetic foot ulcers and their complications. But it, and the NIH, need to invest more in research on…